Amir Abbas Hamidi

Dr. Amir Abbas Hamidi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2022 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
AHAmir Abbas Hamidi
Amir Abbas Hamidi
AAAmir Avan
Amir Avan
ZNZahra Nasrpour Navaei
Zahra Nasrpour Navaei
MMMeysam Moghbeli
Meysam Moghbeli
Colorectal cancer (CRC) is the second most common cause of cancer mortality and a major health challenge worldwide. Despite advances in therapeutic and diagnostic methods, there is still a poor prognosis in CRC patients. Tumor recurrence and metastasis are the main causes of high mortality rate in these patients, which are due to late diagnosis in advanced tumor stages. Epithelial-mesenchymal transition (EMT) is known to be the most important cause of CRC metastasis, during which tumor cells obtain metastasis ability by losing epithelial features and gaining mesenchymal features. Long non-coding RNAs (lncRNAs) are pivotal regulators of EMT process. Regarding the higher stability of lncRNAs compared with coding RNAs in body fluids, they can be used as non-invasive diagnostic markers for EMT process. In the present review, we summarized all of the lncRNAs involved in regulation of EMT process during CRC progression and metastasis. It was observed that lncRNAs mainly induced the EMT process in CRC cells by regulation of EMT-related transcription factors, Poly comb repressive complex (PRC), and also signaling pathways such as WNT, NOTCH, MAPK, and Hippo.

4 June 2022 in Biomarker Research
Verified
Journal Article
Open access
PDF file
AHAmir Abbas Hamidi
Amir Abbas Hamidi
NTNegin Taghehchian
Negin Taghehchian
ZBZahra Basirat
Zahra Basirat
AZAmir Sadra Zangouei
Amir Sadra Zangouei
MMMeysam Moghbeli
Meysam Moghbeli
Thyroid cancer (TC) is one of the most frequent endocrine malignancies that is more common among females. Tumor recurrence is one of the most important clinical manifestations in differentiated TC which is associated with different factors including age, tumor size, and histological features. Various molecular processes such as genetic or epigenetic modifications and non-coding RNAs are also involved in TC progression and metastasis. The epithelial-to-mesenchymal transition (EMT) is an important biological process during tumor invasion and migration that affects the initiation and transformation of early-stage tumors into invasive malignancies. A combination of transcription factors, growth factors, signaling pathways, and epigenetic regulations affect the thyroid cell migration and EMT process. MicroRNAs (miRNAs) are important molecular factors involved in tumor metastasis by regulation of EMT-activating signaling pathways. Various miRNAs are involved in the signaling pathways associated with TC metastasis which can be used as diagnostic and therapeutic biomarkers. Since, the miRNAs are sensitive, specific, and non-invasive, they can be suggested as efficient and optimal biomarkers of tumor invasion and metastasis. In the present review, we have summarized all of the miRNAs which have been significantly involved in thyroid tumor cells migration and invasion. We also categorized all of the reported miRNAs based on their cellular processes to clarify the molecular role of miRNAs during thyroid tumor cell migration and invasion. This review paves the way of introducing a non-invasive diagnostic and prognostic panel of miRNAs in aggressive and metastatic TC patients.

22 October 2026 in Experimental Hematology & Oncology
Verified
Journal Article
Open access
PDF file
AHAmir Abbas Hamidi
Amir Abbas Hamidi
OMOmeed Moaven
Omeed Moaven
RMReihaneh Alsadat Mahmoudian
Reihaneh Alsadat Mahmoudian
MAMohammad Reza Abbaszadegan
Mohammad Reza Abbaszadegan
Direct RAS targeting has progressed from pharmacologic proof of concept to routine treatment for selected KRAS G12C-mutant cancers. KRAS G12C inhibitors an